Commercializing Industrial Biotechnology 2019

Exploring the Global Impact of Industrial Biotechnology
May 13-14, 2019
Add to Calendar

This 2 day-conference on Technology Challenges and Opportunities in Commercializing Industrial Biotechnology will take place at The DoubleTree by Hilton Los Angeles from May 13th to 14th in Los Angeles, California. 

Registration is Now Open

Conference Flyer

AIChE’s thoughts are with those affected by the California wildfires and the first responders doing all they can to help.​

Call for Abstracts is now open until March 22nd, 2019

Submit your abstract here

Biobased production of industrial chemicals, fuels, and specialties (industrial biotech) has had many triumphant moments in the last few decades.  Along with these successes, however, industrial biotech has also faced and had to overcome challenges, disappointments, and delays.  We seem now to be at a turning point where regulatory and environmental factors, customer and consumer awareness, and technology progress are aligning – signaling and ushering in a golden era.  At this point, success for any biobased product should be viewed as a common achievement for all players in the field; it raises credibility and excitement across the industry, including with investors.  “Commercializing Industrial Biotechnology” is a workshop where industrial biotech thought leaders – in particular, those who have been through it all – will share their experiences and their views on current challenges. The outcome is a sharing of common learnings that can help us all advance further and together!

The theme of the 2019 conference is the Global Impact of Industrial Biotechnology. The conference will explore ways in which biotech is growing into new markets.

Sessions:

  • Market pull - The changing consumer landscape
  • Advancements enabling a new wave of products
  • Feedstocks - Can cost and other advantages be realized with non-traditional feedstocks?
  • Investment trends - What is driving the increased access to new sources of capital flowing into industrial biotechnology? 
  • Deployment - Diverse strategies (and locations) for advancing products from the lab through piloting and on to full manufacturing? 
  • From commodities to fine chemicals - Examples of how and why biotech can compete? 

Submit your abstract here

Keynote Speaker

Invited Speakers

Conference Chairs

  • Kevin Madden, Ginkgo Bioworks
  • Todd Pray, US DOE Berkeley National Lab

Organizing Committee

  • Doug Cameron, First Green Partners
  • Bo Chen, Genomatica
  • Joel Cherry, Amyris
  • Brian Davison, Oak Ridge National Laboratory
  • Jeff Lievense, Genomatica

Highlights

Featured Speakers

Randy Berka

Dr. Berka is an experienced molecular biologist and research director whose career spans more than 35 years of microbial strain development for the application of enzymes in industrial biotechnology. He currently manages ADM’s enzyme development laboratory in Davis, CA.Read more

Joško Bobanović

Joško Bobanović joined Sofinnova Partners in 2010 as Partner dedicated to activities in industrial biotech. He focuses on early stage deals in Europe and North America with applications in chemicals, agriculture, food, feed and synthetic biology. Joško sits on the boards of Metgen, Synthace, Cellucomp, Comet Bio, DNA Script and Biosyntia. Prior to joining Sofinnova he spent eight years in venture capital with iNovia Capital in Montreal, Canada. Prior to his venture capital career he created an internet startup and a software company. After completing his PhD studies Joško developed real-...Read more

Daniel MacEachran

Dan currently serves as the Head of Open Innovation for Braskem’s Renewable Chemicals and Materials group. In this role, he and his team are responsible for accelerating the flow of new technologies into and through Braskem’s Renewables R&D pipeline via the identification and participation in mutually beneficial collaborations.Read more

Henk Noorman

Henk Noorman is currently working as Corporate Science Fellow Engineering Sciences in the DSM Biotechnology Center and involved in numerous projects in Industrial Biotechnology, Food Specialties, Anti-Infectives and the Corporate Research Program. In addition, he is honorary professor at the Technical University Delft, conducting research and teaching in Bioprocess Design and Integration.Read more

Alex Patist

Alex has over 20 years of experience in directing new product, process development, and scale-up in the food, nutraceutical, biochemical & biofuels industries. Since 2017, he took on the role of VP of Process Development at Bolt Threads, managing fermentation, recovery, fibers and Mylo(TM) development, scale-up and tech transfer.Read more

Emmanuel Petiot

Emmanuel Petiot's role in Deinove is to make sure that the company strikes the right technology and commercial partnerships as well as further strengthens its R&D and Operational structures to accelerate industrialization of its breakthrough bio-based solutions.Read more

Jenny Rooke

Jenny Rooke brings a combination of strategy, operating, and investing experience to her work with life sciences companies, specializing in research tools, diagnostics, and synthetic biology. Dr. Rooke is founder and Managing Director of Genoa Ventures, which invests in early-stage companies innovating at the intersection of biology and technology. Her previous investing roles include Venture Partner at F-Prime Capital (formerly Fidelity Biosciences), where she also served her Kauffman Fellowship, and Anterra Capital, the world’s largest food and Ag-focused fund. Previously, Jenny served...Read more

Shawn Semones

Dr. Semones is a distinguished research and development director whose recent work has focused on the applied discovery of microbial technology for agriculture.

Dr. Semones has more than 18 years of experience at Novozymes Biologicals, Inc., where he helped build its BioAg R&D Application Division. Most recently, he was Director of BioAg R&D Application Development and Novozymes Biologicals Site Lead, directing R&D efforts across three sites within North America, as well as a global field R&D team. He has been the R&D lead for the BioAg Alliance, the strategic...Read more

Smita Shankar

My name is Smita Shankar and I am Director of Research at Impossible foods.

Animal farming is one of the largest contributors to global climate change. At Impossible foods, we’re trying to reduce the impact of animal farming on the planet by creating a delicious burger made entirely out of plant materials. A key driver of flavor in beef is heme, a molecule found in animal muscle. We use yeast fermentation to make soybean Leghemoglobin, the heme protein that is the key ingredient of the Impossible burger.

My background is in molecular biology and yeast genetics. I joined IF as...Read more

Kelly Smith

An experienced biotechnology innovator, Kelly Smith returned to the entrepreneurial community in 2014. She formed the fermentation and formulation research team at AgBiome, after serving as Head of Pasteuria Bioscience for Syngenta Crop Protection.Read more